Beijing Centergate Technologies Holding Co Ltd
Beijing Centergate Technologies (holding) Co., Ltd. engages in the pharmaceutical industry in China and internationally. The company offers Anemarrhena saponin BII and capsules for vascular dementia treatment; Bifonazole API, an opioid receptor antagonist; Naloxone Hydrochloride injection to relieve acute ethanol poisoning; Naltrexone Hydrochloride tablets to block the pharmacological effects of … Read more
Beijing Centergate Technologies Holding Co Ltd - Asset Resilience Ratio
Beijing Centergate Technologies Holding Co Ltd (000931) has an Asset Resilience Ratio of 0.06% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2024)
This chart shows how Beijing Centergate Technologies Holding Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Beijing Centergate Technologies Holding Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥2.17 Million | 0.06% |
| Total Liquid Assets | CN¥2.17 Million | 0.06% |
Asset Resilience Insights
- Limited Liquidity: Beijing Centergate Technologies Holding Co Ltd maintains only 0.06% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Beijing Centergate Technologies Holding Co Ltd Industry Peers by Asset Resilience Ratio
Compare Beijing Centergate Technologies Holding Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Blue Sail Medical Co Ltd
SHE:002382 |
Medical Instruments & Supplies | 5.12% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 35.75% |
|
Allmed Medical Products Co Ltd Class A
SHE:002950 |
Medical Instruments & Supplies | 3.78% |
|
Inix Technologies Holdings Bhd
KLSE:0094 |
Medical Instruments & Supplies | 0.06% |
|
Focus Point Holdings Bhd
KLSE:0157 |
Medical Instruments & Supplies | 2.30% |
|
Careplus Group Bhd
KLSE:0163 |
Medical Instruments & Supplies | 4.91% |
|
LKL International Bhd
KLSE:0182 |
Medical Instruments & Supplies | 0.38% |
|
Visco Vision Inc.
TW:6782 |
Medical Instruments & Supplies | 0.98% |
Annual Asset Resilience Ratio for Beijing Centergate Technologies Holding Co Ltd (1999–2024)
The table below shows the annual Asset Resilience Ratio data for Beijing Centergate Technologies Holding Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.06% | CN¥2.17 Million | CN¥3.71 Billion | -0.01pp |
| 2023-12-31 | 0.07% | CN¥2.76 Million | CN¥3.78 Billion | -0.06pp |
| 2022-12-31 | 0.13% | CN¥4.70 Million | CN¥3.54 Billion | 0.00pp |
| 2021-12-31 | 0.13% | CN¥4.97 Million | CN¥3.70 Billion | -0.04pp |
| 2020-12-31 | 0.17% | CN¥5.96 Million | CN¥3.46 Billion | +0.02pp |
| 2019-12-31 | 0.15% | CN¥5.41 Million | CN¥3.58 Billion | -0.01pp |
| 2011-12-31 | 0.16% | CN¥7.00 Million | CN¥4.33 Billion | -0.09pp |
| 2003-12-31 | 0.25% | CN¥18.93 Million | CN¥7.46 Billion | -0.15pp |
| 2002-12-31 | 0.40% | CN¥29.67 Million | CN¥7.40 Billion | -0.17pp |
| 2001-12-31 | 0.57% | CN¥55.03 Million | CN¥9.69 Billion | -1.91pp |
| 2000-12-31 | 2.48% | CN¥163.85 Million | CN¥6.60 Billion | -6.64pp |
| 1999-12-31 | 9.13% | CN¥285.00 Million | CN¥3.12 Billion | -- |